Tweet
Town Hall
<img alt="" height="1" width="1" />
FDA Panel Rejects Prostate Drugs for CA Prevention
MedPage Today
SILVER SPRING, Md. -- An FDA advisory panel has voted overwhelmingly that GlaxoSmithKline's dutasteride (Avodart) and Merck's finasteride (Proscar) should not be used to prevent prostate ...
FDA panel rejects Merck drug for prostate cancerBusinessWeek
FDA Panel Votes Against Avodart, Proscar To Prevent Prostate CancerWall Street Journal
Merck's Proscar Fails to Win US FDA Panel's BackingBloomberg
San Antonio Express -abc7.com -PR Newswire (press release)
all 195 news articles »
More...